CDC42 and glioblastoma: The interaction of CDC42 in complex with CASIN exhibited binding energy of (−7.4 kcal/mol) and MAPK7 in complex with BAY-885 displayed binding energy of (−7.3 kcal/mol), these results exhibited a much lower binding affinities as compared to SJ10, this suggesting the potential inhibitory effects of SJ10 in GBM expression CCNB1, CDC42, MAPK7, and CD44 oncogenic signatures (Figure 12, Table 2).